Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 19 Dec 2024 15:37 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Primary insider notification | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 19 Dec 2024 09:01 CET |
EXACT THERAPEUTICS | EXACT Therapeutics Expands its Board of Directors following the EGM | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Dec 2024 11:36 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Cancellation of subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Dec 2024 12:00 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Minutes from the extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2024 08:00 CET |
EXACT THERAPEUTICS | EXACT Therapeutics Announces FDA Clearance of IND for ENACT, a Phase 2 Trial in Pancreatic Cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Dec 2024 18:47 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Primary insider notification | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 11 Dec 2024 11:44 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 03 Dec 2024 14:23 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Notice of extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2024 08:21 CET |
EXACT THERAPEUTICS | EXACT Therapeutics to host virtual company presentation on December 4, 2024 following the announcement of completion of private placement | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Dec 2024 00:12 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Key information regarding potential subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2024 00:08 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Private placement successfully placed | 20103010 Biotechnology | Inside information |
| 02 Dec 2024 16:38 CET |
EXACT THERAPEUTICS | EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer using ACT® | 20103010 Biotechnology | Inside information |
| 02 Dec 2024 16:30 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Contemplated Private Placement | 20103010 Biotechnology | Inside information |
| 08 Oct 2024 10:04 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenus Inc. | 20103010 Biotechnology | Non-regulatory press releases |
| 02 Oct 2024 08:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics to Present at the bi-annual Contrast Media Research (CMR) Symposium 2024 | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Sep 2024 08:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces first half 2024 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 25 Sep 2024 09:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces grant of immunotherapy patent | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Sep 2024 20:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics to Present at the Annual International Symposium on Therapeutic Ultrasound (ISTU 2024) | 20103010 Biotechnology | Non-regulatory press releases |
| 13 Sep 2024 15:18 CEST |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Aug 2024 18:33 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics Company update: Full focus on Phase 2 pancreatic cancer trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Jun 2024 11:47 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics minutes from Annual General Meeting June 28, 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Jun 2024 09:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Notice of Annual General Meeting 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2024 09:23 CEST |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Apr 2024 20:46 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics Annual report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
| 10 Apr 2024 08:57 CEST |
EXACT THERAPEUTICS | Additional promising clinical data from EXACT Therapeutics’ ongoing ACTIVATE study presented at AACR Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Mar 2024 21:05 CET |
EXACT THERAPEUTICS | EXACT Therapeutics to Present at 2024 American Association for Cancer Research (AACR) Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Jan 2024 14:09 CET |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Dec 2023 11:41 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS – Share capital increase registered. Correction. | 20103010 Biotechnology | Total number of voting rights and capital |
| 20 Dec 2023 10:43 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS – Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 14 Dec 2023 09:45 CET |
EXACT THERAPEUTICS | EXACT Therapeutics presenting at DNB Nordic Healthcare conference December 14 | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Dec 2023 08:46 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Primary insider notices | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 Nov 2023 22:30 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Private placement successfully placed | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Nov 2023 16:30 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Contemplated Private Placement | 20103010 Biotechnology | Inside information |
| 31 Oct 2023 10:48 CET |
EXACT THERAPEUTICS | EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital | 20103010 Biotechnology | Non-regulatory press releases |
| 16 Oct 2023 16:35 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS – Issuance of share options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 12 Oct 2023 08:49 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Sep 2023 08:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces first half 2023 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 27 Sep 2023 14:55 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Sep 2023 08:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces positive clinical results from the ACTIVATE Phase I dose escalation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Sep 2023 08:41 CEST |
EXACT THERAPEUTICS | Invitation to first half results 2023 presentation of EXACT Therapeutics AS | 20103010 Biotechnology | Non-regulatory press releases |
| 13 Sep 2023 09:16 CEST |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Sep 2023 09:48 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics and Cordance Medical Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Aug 2023 09:57 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics completed the dose escalation part of ACTIVATE study | 20103010 Biotechnology | Non-regulatory press releases |
| 31 Jul 2023 13:02 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics receives regulatory approval to start the dose expansion part of ACTIVATE study | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Jun 2023 12:39 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics minutes from Annual General Meeting June 9, 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 May 2023 09:14 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Notice of Annual General Meeting 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 May 2023 11:43 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics Announces Granted Patent in United Kingdom for Acoustic Cluster Therapy (ACT®) | 20103010 Biotechnology | Non-regulatory press releases |
| 21 Apr 2023 17:42 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS announces the publication of the 2022 Annual Report | 20103010 Biotechnology | Annual financial and audit Reports |
| 28 Mar 2023 08:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics presents encouraging clinical case report data at Science & Technology Event | 20103010 Biotechnology | Non-regulatory press releases |
| 02 Feb 2023 13:13 CET |
EXACT THERAPEUTICS | Exact Therapeutics receives regulatory approval to reopen the ACTIVATE clinical trial | 20103010 Biotechnology | Non-regulatory press releases |